Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-122442
Filing Date
2023-04-27
Accepted
2023-04-27 16:44:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d470057d424b5.htm 424B5 7814
2 GRAPHIC g470057g0426014037574.jpg GRAPHIC 2843
  Complete submission text file 0001193125-23-122442.txt   13029
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

EIN.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-268288 | Film No.: 23857914
SIC: 2836 Biological Products, (No Diagnostic Substances)